CHARLES SCHWAB INVESTMENT MANAGEMENT INC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$5,317,559
-21.6%
276,668
+3.7%
0.00%0.0%
Q2 2023$6,782,615
-28.5%
266,822
+1.6%
0.00%
-33.3%
Q1 2023$9,492,665
-8.6%
262,591
+0.2%
0.00%0.0%
Q4 2022$10,381,457
-12.7%
262,158
+2.7%
0.00%
-25.0%
Q3 2022$11,894,000
+9.0%
255,217
+2.5%
0.00%0.0%
Q2 2022$10,916,000
-40.4%
249,049
-1.6%
0.00%
-33.3%
Q1 2022$18,313,000
-8.2%
253,182
+2.9%
0.01%0.0%
Q4 2021$19,939,000
-29.4%
245,945
+1.4%
0.01%
-33.3%
Q3 2021$28,238,000
-33.3%
242,631
-5.0%
0.01%
-35.7%
Q2 2021$42,344,000
+21.4%
255,405
+2.1%
0.01%
+7.7%
Q1 2021$34,883,000
-13.6%
250,056
+7.2%
0.01%
-18.8%
Q4 2020$40,381,000
+25.8%
233,278
+1.2%
0.02%
+6.7%
Q3 2020$32,111,000
+13.8%
230,515
-2.4%
0.02%
+7.1%
Q2 2020$28,224,000
+47.0%
236,236
+23.0%
0.01%
+27.3%
Q1 2020$19,198,000
-13.2%
192,014
+2.0%
0.01%
-8.3%
Q4 2019$22,124,000
+39.7%
188,219
+2.2%
0.01%
+33.3%
Q3 2019$15,832,000
+38.1%
184,146
+4.2%
0.01%
+28.6%
Q2 2019$11,461,000
+6.6%
176,781
+2.8%
0.01%0.0%
Q1 2019$10,751,000
+68.0%
171,980
+4.5%
0.01%
+40.0%
Q4 2018$6,398,000
-31.5%
164,498
+0.4%
0.01%
-16.7%
Q3 2018$9,335,000
-20.6%
163,762
+11.2%
0.01%
-33.3%
Q2 2018$11,762,000
-1.8%
147,299
+6.6%
0.01%0.0%
Q1 2018$11,972,000
+32.4%
138,126
+5.5%
0.01%
+28.6%
Q4 2017$9,044,000
-23.8%
130,987
+0.3%
0.01%
-30.0%
Q3 2017$11,873,000
+49.6%
130,642
+22.6%
0.01%
+42.9%
Q2 2017$7,935,000
-10.6%
106,598
+12.6%
0.01%
-22.2%
Q1 2017$8,874,000
+43.2%
94,705
+11.0%
0.01%
+28.6%
Q4 2016$6,198,000
-26.8%
85,300
+5.2%
0.01%
-30.0%
Q3 2016$8,465,000
+77.2%
81,084
+25.2%
0.01%
+66.7%
Q2 2016$4,776,000
+60.2%
64,746
+22.2%
0.01%
+50.0%
Q1 2016$2,982,000
-15.1%
52,994
+1.8%
0.00%
-20.0%
Q4 2015$3,514,000
+65.4%
52,044
+13.6%
0.01%
+66.7%
Q3 2015$2,125,000
+12.4%
45,796
+30.2%
0.00%0.0%
Q2 2015$1,891,000
+123.5%
35,169
+99.3%
0.00%
+200.0%
Q1 2015$846,000
+29.8%
17,650
+4.8%
0.00%0.0%
Q4 2014$652,00016,8380.00%
Other shareholders
NEVRO CORP shareholders Q1 2023
NameSharesValueWeighting ↓
BRAIDWELL LP 1,192,298$47,215,0011.58%
Altium Capital Management LP 76,000$3,009,6001.53%
Rock Springs Capital Management LP 1,077,900$42,684,8401.03%
Integral Health Asset Management, LLC 109,000$4,316,4000.91%
ArrowMark Colorado Holdings LLC 1,252,218$49,587,8330.59%
FOX RUN MANAGEMENT, L.L.C. 26,963$1,067,7350.43%
PDT Partners, LLC 55,715$2,206,3140.36%
FRED ALGER MANAGEMENT, LLC 1,184,000$46,886,4000.25%
Dynamic Technology Lab Private Ltd 62,819$2,4880.25%
K2 PRINCIPAL FUND, L.P. 38,000$1,504,8000.23%
View complete list of NEVRO CORP shareholders